Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine for platelet activation and inflammation in older adults without cardiovascular disease
ACTRN12622000585729Phase 4Recruiting
- Sponsor
- Concord Hospital
- Start
- Apr 2022
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of colchicine in cardiac morbidity (2 arms), sponsored by Concord Hospital. Primary endpoint: Change in platelet function with stimulation. Started Apr 2022; status: recruiting.
02
Drugs
colchicine
03
Conditions
cardiac morbidity
Beyond the preview
Go deeper on ACTRN12622000585729.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12622000585729.